📄 Certificate of Analysis available on request
Restock in progress. Add your email and we will tell you the moment this compound is back in stock.
One email when this is back in stock. No spam, unsubscribe anytime.
Testagen is a synthetic short-peptide bioregulator from the Khavinson family of low-molecular-weight regulatory peptides, the same structural class as Epithalon and Pinealon. It is a short chain of amino-acid residues rather than a protein, supplied as a defined synthetic compound.
In the published preclinical literature, Testagen has been characterised at the molecular level for how a short peptide of this class is taken up by cultured cells and how it associates, in cell-free assays, with deoxyribonucleotides, DNA, and histone-DNA complexes, alongside animal-model work recording endocrine-tissue endpoints. It is supplied as a research compound and is not intended for human or veterinary use.
Testagen has been characterised in preclinical laboratory models. The primary studies below, in cultured cells, cell-free binding assays, and an animal endocrine model, recorded uptake, binding, and tissue-level endpoints, with the work centred on how a short peptide of this class is handled by cells and how it associates with DNA and histones. The literature is thin and preclinical; it describes the compound, not any outcome in humans.
In vitro
Penetration of short fluorescence-labelled peptides into the nucleus in HeLa cells and in-vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA
In cultured HeLa cells, the localisation of FITC-labelled Lys-Glu-Asp-Gly (named in the report as testagen) was tracked into the cytoplasm, nucleus, and nucleolus, and in cell-free assays fluorescence quenching was used to measure the peptide’s binding to deoxyribooligonucleotides and DNA as the recorded interaction endpoints.
Read the study ↗
In vitro
Interaction of short peptides with FITC-labelled wheat histones and their complexes with deoxyribooligonucleotides
In cell-free assays, fluorescence quenching was used to measure the binding of six short peptides, Lys-Glu-Asp-Gly included by sequence, to FITC-labelled wheat histones and to histone-deoxyribooligonucleotide complexes, mapping the association with the N-terminal histone regions as the measured endpoint.
Read the study ↗
Full documentation, on the record. A Certificate of Analysis and a Safety Data Sheet are available on request for every batch.
Links open the original study on PubMed. For research and educational purposes, descriptive of the published preclinical literature, not therapeutic claims about any ai-peptides product.
